YFY is one of the most important pioneers of Taiwan’s biotechnology industry. Far from simply investing in R&D, the company has focused on developing and nurturing the biotech sector as a whole over the past 30 years. Upholding YFY’s long-term operating principles, the group carries out strategic investments in the medical biotechnology sector through targeting high-potential enterprises in the med-tech, biopharma and diagnostic fields for investment and management assistance. The group offers these targets operational and OTC or exchange-listing support, as well as guidance on securing more funds and market-side assistance.
